 Morgan Stanley decreased its stake in shares of Eidos Therapeutics Inc NASDAQ:EIDX by 91.0 during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,306 shares of the companys stock after selling 33,530 shares during the period. Morgan Stanleys holdings in Eidos ... 